SynthesisBrain and behavior2026
Behavioral Activation for Depression and Glycemic Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Synthesis in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionDepression in type 2 diabetes mellitus (T2DM) hinders self-management and glycemic control. Behavioral activation (BA), by increasing participation in positive activities, holds promise for simultaneously improving depressive symptoms and diabetes outcomes.
objectiveThis study evaluated the effects of BA or BA-based interventions on depressive symptoms, glycated hemoglobin (HbA1c), diabetes self-efficacy, and self-management behaviors in adults with T2DM, and summarized their implementation characteristics. METHODOLOGY: PubMed, Web of Science, Embase, Cochrane Library, PsycINFO, CNKI, VIP, and Wanfang Data were searched from inception to February 1, 2026. Interventional studies assessing BA or BA-based interventions in adults with T2DM and reporting at least one prespecified outcome were included. Quantitative meta-analyses were restricted to randomized controlled trials (RCTs) and conducted using random-effects models. Implementation characteristics from all included studies were narratively synthesized.
resultsSix studies involving 252 participants met the inclusion criteria, including five RCTs and one single-arm pre-post study. The meta-analysis suggested a reduction in depressive symptoms (SMD = -0.81, 95% CI: -1.22 to -0.41, p < 0.001), but no statistically significant effects on HbA1c (MD = -0.04%, 95% CI: -0.30 to 0.22, p = 0.76), diabetes self-efficacy (SMD = 0.03, 95% CI: -0.30 to 0.35, p = 0.87), or self-management behaviors (SMD = 0.04, 95% CI: -0.23 to 0.32, p = 0.77). Narrative synthesis indicated that BA interventions varied in delivery format, dosage, provider background, and integration with diabetes-specific content. Most interventions were delivered by non-mental health professionals and incorporated core BA components such as activity monitoring and goal setting.
conclusionBA may reduce depressive symptoms in adults with T2DM, whereas its effects on glycemic control, diabetes self-efficacy, and self-management behaviors remain uncertain. BA has been delivered in flexible formats and may have potential for integration into diabetes care, but larger, well-powered RCTs with longer follow-up are needed to determine whether diabetes-specific BA can improve behavioral and physiological outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.